Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Delauche

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|June 15, 1991
Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF GroupA Jardin, H Bensadoun, M C Delauche-Cavallier, et al.
British Journal of Urology|May 23, 1998
Clinical uroselectivity: evidence from patients treated with slow release alfuzosin for symptomatic benign prostatic obstructionJ M Buzelin, M C Delauche Cavallier, D Martin, et al.
La Nouvelle Presse Medicale|May 15, 1982
[Myasthenic syndrome induced by D-penicillamine. Changes in serum levels of acetylcholine receptor antibodies]F Woimant, L Benacin, M C Delauche, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1981
[Condensing plasmacytoma and polyneuropathy. Apropos of a new case]M C Delauche, J P Clauvel, A Hubault, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|May 1, 1977
[Diagnostic value of synovial membrane immunofluorescence]A P Peltier, M C Delauche, L Cyna, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|October 1, 1977
[Frequency of radiologic chondrocalcinosis in patients over 80 years of age. A prospective study]M C Delauche, B Stehle, B Cassou, et al.
European Urology|January 1, 1997
Efficacy and safety of sustained-release alfuzosin 5 mg in patients with benign prostatic hyperplasia. ALGEBI Study GroupJ M Buzelin, S Roth, C Geffriaud-Ricouard, et al.
British Journal of Urology|November 1, 1994
Long-term treatment of benign prostatic hyperplasia with alfuzosin: a 24-30 month survey. BPHALF GroupA Jardin, H Bensadoun, M C Delauche-Cavallier, et al.
Annales De Medecine Interne|January 1, 1980
[Vascular and obstetrical prognosis after hypertension during pregnancy: value of renal biopsy (author's transl)]M Beaufils, M C Delauche, L Morel-Maroger, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 12, 1999
QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamineM C Delauche-Cavallier, S Chaufour, E Guérault, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|June 15, 1991
Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF GroupA Jardin, H Bensadoun, M C Delauche-Cavallier, et al.
British Journal of Urology|May 23, 1998
Clinical uroselectivity: evidence from patients treated with slow release alfuzosin for symptomatic benign prostatic obstructionJ M Buzelin, M C Delauche Cavallier, D Martin, et al.
La Nouvelle Presse Medicale|May 15, 1982
[Myasthenic syndrome induced by D-penicillamine. Changes in serum levels of acetylcholine receptor antibodies]F Woimant, L Benacin, M C Delauche, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1981
[Condensing plasmacytoma and polyneuropathy. Apropos of a new case]M C Delauche, J P Clauvel, A Hubault, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|May 1, 1977
[Diagnostic value of synovial membrane immunofluorescence]A P Peltier, M C Delauche, L Cyna, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|October 1, 1977
[Frequency of radiologic chondrocalcinosis in patients over 80 years of age. A prospective study]M C Delauche, B Stehle, B Cassou, et al.
European Urology|January 1, 1997
Efficacy and safety of sustained-release alfuzosin 5 mg in patients with benign prostatic hyperplasia. ALGEBI Study GroupJ M Buzelin, S Roth, C Geffriaud-Ricouard, et al.
British Journal of Urology|November 1, 1994
Long-term treatment of benign prostatic hyperplasia with alfuzosin: a 24-30 month survey. BPHALF GroupA Jardin, H Bensadoun, M C Delauche-Cavallier, et al.
Annales De Medecine Interne|January 1, 1980
[Vascular and obstetrical prognosis after hypertension during pregnancy: value of renal biopsy (author's transl)]M Beaufils, M C Delauche, L Morel-Maroger, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 12, 1999
QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamineM C Delauche-Cavallier, S Chaufour, E Guérault, et al.
Pageof 4